Amicus Therapeutics, Inc. (FOLD)
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Investigation
07/25/2022
Initial Lawsuit
07/29/2022
Lawsuit Progression
09/27/2022
Did Weber Inc. mislead investors regarding its demand and guidance for the year 2022? Was the company’s IPO a false representation of its prospects and financials?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We update this post regularly.
07/25/2022
Weber announces the departure of its CEO Chris Scherzinger along with its Q3 2022 financial results.
Weber reports lower than expected results “affected by slower retail traffic, both in-store and online, in all key markets, as well as continued foreign currency devaluations that impact our reported results.”
“Management believes that the slower retail traffic patterns are the result of pressured consumer shopping behaviors globally, due to rising inflation, supply chain constraints, fuel prices, and geopolitical uncertainty. The Company expects these market headwinds to continue into the fiscal fourth quarter of 2022.” As a result, Weber withdrew its guidance for the fiscal year.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$6.56 | $7.51 | $-0.95 | -12.65% |
A Weber Inc. investor filed a securities class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Weber Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the August 2021 initial public offering (IPO).
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that Weber was reasonably likely to implement price increases;
(2) that, as a result, consumer demand for Weber’s products was reasonably likely to decrease;
(3) that, due to the resulting inventory buildup, Weber was reasonably likely to run promotions to “enhance retail sellthrough”;
(4) that the foregoing would adversely impact Weber’s financial results; and
(5) that, as a result of the foregoing, the defendants’ positive statements about the company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.